X4 Pharmaceuticals, Inc. (XFOR)
4.235
-0.06
(-1.51%)
USD |
NASDAQ |
Dec 30, 09:31
X4 Pharmaceuticals Research and Development Expense (Quarterly): 17.31M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Altimmune, Inc. | 14.93M |
| Adverum Biotechnologies, Inc. | 38.91M |
| Recursion Pharmaceuticals, Inc. | 107.66M |
| Quantum-Si, Inc. | 13.88M |